Hideo Michibata

Title: Hideo Michibata: Innovator in Phosphodiesterase Research

Introduction

Hideo Michibata is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of phosphodiesterases. With a total of 2 patents to his name, Michibata's work has implications for various therapeutic applications.

Latest Patents

Michibata's latest patents focus on novel phosphodiesterases and their associated genes. One of his key inventions is related to Type 11 phosphodiesterase (PDE11). This invention provides a phosphodiesterase selected from proteins with specific amino acid sequences, which can hydrolyze cyclic nucleotides. Additionally, he has developed methods for characterizing, identifying, and selecting phosphodiesterase inhibitors using these proteins.

Career Highlights

Hideo Michibata is currently employed at Tanabe Seiyaku Company, Limited, where he continues to advance his research in phosphodiesterases. His work has garnered attention in the scientific community for its potential applications in drug development and therapeutic interventions.

Collaborations

Some of Michibata's notable coworkers include Kotomi Oda and Keizo Yuasa. Their collaborative efforts contribute to the innovative research environment at Tanabe Seiyaku Company.

Conclusion

Hideo Michibata's contributions to the field of phosphodiesterase research highlight his role as an influential inventor. His patents reflect a commitment to advancing scientific knowledge and developing new therapeutic options.